Cargando…
XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications
Purpose. To evaluate gel microstent (XEN, Aquesys, Inc) for treatment of primary open angle glaucoma (POAG). Methods. In this prospective interventional study, 13 eyes with POAG underwent XEN implantation with subconjunctival mitomycin-C. Of those eyes, 3 were pseudophakic and 10 underwent simultane...
Autores principales: | Galal, Ahmed, Bilgic, Alper, Eltanamly, Rasha, Osman, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350531/ https://www.ncbi.nlm.nih.gov/pubmed/28348884 http://dx.doi.org/10.1155/2017/5457246 |
Ejemplares similares
-
A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient
por: Baeg, Joon Young, et al.
Publicado: (2023) -
XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long-Term Follow-Up
por: Lewczuk, Katarzyna, et al.
Publicado: (2021) -
Results of Combined Cyclectomy/Trabeculectomy Procedure Compared with Ahmed Glaucoma Valve Implant in Neovascular Glaucoma Cases
por: Engin, Kaya N., et al.
Publicado: (2011) -
A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma
por: Singab, Alaa Abdel Sadek, et al.
Publicado: (2017) -
Italian Candidates for the XEN Implant: An Overview from the Glaucoma Treatment Registry (XEN-GTR)
por: Posarelli, Chiara, et al.
Publicado: (2022)